Close Menu

Hitting the Big-Time

FDA has approved Novartis' Ilaris to treat a rare, genetic autoinflammatory disease, reports the Wall Street Journal. The paper's Health Blog adds that Ilaris is an example of that prized goal, personalized medicine. "It's also the first concrete result of Novartis's seven-year effort to target the genetic causes of disease.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

SARS-CoV-2 vaccine developers are evaluating further vaccine doses as well as modified doses to keep up with new viral variants, according to CNN.

The New York Times reports that a new viral variant of concern has been identified in New York City.

In Nature this week: spatiotemporally resolved map of the human cell cycle, folding single-cell RNA sequencing into cancer drug studies, and more.

According to BBC News, the global vaccine-sharing initiative has sent its first shipment, which arrived in Ghana this week.